COGT logo

Cogent Biosciences, Inc. (COGT) Cash From Financing

Annual CFF:

$214.45M+$50.91M(+31.13%)
December 31, 2024

Summary

  • As of today, COGT annual cash from financing is $214.45 million, with the most recent change of +$50.91 million (+31.13%) on December 31, 2024.
  • During the last 3 years, COGT annual cash from financing has risen by +$176.47 million (+464.70%).
  • COGT annual cash from financing is now -7.64% below its all-time high of $232.20 million, reached on December 31, 2020.

Performance

COGT Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTcash flow metrics

Quarterly CFF:

$217.37M+$170.14M(+360.26%)
September 30, 2025

Summary

  • As of today, COGT quarterly cash from financing is $217.37 million, with the most recent change of +$170.14 million (+360.26%) on September 30, 2025.
  • Over the past year, COGT quarterly cash from financing has increased by +$216.74 million (+34734.46%).
  • COGT quarterly cash from financing is now at all-time high.

Performance

COGT Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTcash flow metrics

TTM CFF:

$289.59M+$216.74M(+297.53%)
September 30, 2025

Summary

  • As of today, COGT TTM cash from financing is $289.59 million, with the most recent change of +$216.74 million (+297.53%) on September 30, 2025.
  • Over the past year, COGT TTM cash from financing has increased by +$75.17 million (+35.05%).
  • COGT TTM cash from financing is now -23.22% below its all-time high of $377.15 million, reached on March 31, 2024.

Performance

COGT TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

COGT Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+31.1%+10000.0%+35.0%
3Y3 Years+464.7%+10000.0%+43.9%
5Y5 Years+10000.0%+97.7%+163.1%

COGT Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+464.7%at high>+9999.0%-23.2%+1041.7%
5Y5-Year-7.6%>+9999.0%at high>+9999.0%-23.2%+1041.7%
All-TimeAll-Time-7.6%>+9999.0%at high>+9999.0%-23.2%>+9999.0%

COGT Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$217.37M(+360.3%)
$289.59M(+297.5%)
Jun 2025
-
$47.23M(+89.1%)
$72.85M(+187.2%)
Mar 2025
-
$24.97M(>+9900.0%)
$25.36M(-88.2%)
Dec 2024
$214.45M(+31.1%)
$26.00K(-95.8%)
$214.45M(+0.0%)
Sep 2024
-
$624.00K(+343.8%)
$214.43M(-0.2%)
Jun 2024
-
-$256.00K(-100.1%)
$214.80M(-43.0%)
Mar 2024
-
$214.06M(>+9900.0%)
$377.15M(+130.6%)
Dec 2023
$163.54M(-0.0%)
$0.00(-100.0%)
$163.54M(-0.2%)
Sep 2023
-
$1.00M(-99.4%)
$163.85M(+0.0%)
Jun 2023
-
$162.09M(>+9900.0%)
$163.84M(-0.0%)
Mar 2023
-
$445.00K(+41.3%)
$163.87M(+0.2%)
Dec 2022
$163.56M(+330.7%)
$315.00K(-68.2%)
$163.56M(-18.7%)
Sep 2022
-
$990.00K(-99.4%)
$201.25M(+0.5%)
Jun 2022
-
$162.12M(>+9900.0%)
$200.31M(+424.4%)
Mar 2022
-
$138.00K(-99.6%)
$38.20M(+0.6%)
Dec 2021
$37.98M
$38.01M(>+9900.0%)
$37.98M(-68.9%)
Sep 2021
-
$55.00K(>+9900.0%)
$122.11M(-47.4%)
Jun 2021
-
$0.00(+100.0%)
$231.98M(-0.0%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$85.00K(-100.1%)
$232.04M(-0.1%)
Dec 2020
$232.20M(>+9900.0%)
$122.14M(+11.1%)
$232.20M(+111.0%)
Sep 2020
-
$109.92M(>+9900.0%)
$110.06M(>+9900.0%)
Jun 2020
-
$62.00K(-15.1%)
$135.00K(-20.6%)
Mar 2020
-
$73.00K(>+9900.0%)
$170.00K(+57.4%)
Dec 2019
$108.00K(-99.8%)
$0.00(0.0%)
$108.00K(-78.5%)
Sep 2019
-
$0.00(-100.0%)
$503.00K(-25.8%)
Jun 2019
-
$97.00K(+781.8%)
$678.00K(-99.0%)
Mar 2019
-
$11.00K(-97.2%)
$70.89M(+0.8%)
Dec 2018
$70.35M(+9749.7%)
$395.00K(+125.7%)
$70.35M(+1.6%)
Sep 2018
-
$175.00K(-99.8%)
$69.22M(+0.2%)
Jun 2018
-
$70.31M(>+9900.0%)
$69.05M(+5562.6%)
Mar 2018
-
-$535.00K(+27.1%)
-$1.26M(-73.4%)
Dec 2017
-$729.00K(-1722.5%)
-$734.00K(>-9900.0%)
-$729.00K(>-9900.0%)
Sep 2017
-
$5000.00(>+9900.0%)
$5000.00(>+9900.0%)
Jun 2017
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2017
-
$0.00
$0.00
Dec 2016
-$40.00K(-100.1%)
-
-
Dec 2015
$70.75M
-
-

FAQ

  • What is Cogent Biosciences, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. annual cash from financing year-on-year change?
  • What is Cogent Biosciences, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. quarterly cash from financing year-on-year change?
  • What is Cogent Biosciences, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. TTM cash from financing year-on-year change?

What is Cogent Biosciences, Inc. annual cash from financing?

The current annual cash from financing of COGT is $214.45M

What is the all-time high annual cash from financing for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high annual cash from financing is $232.20M

What is Cogent Biosciences, Inc. annual cash from financing year-on-year change?

Over the past year, COGT annual cash from financing has changed by +$50.91M (+31.13%)

What is Cogent Biosciences, Inc. quarterly cash from financing?

The current quarterly cash from financing of COGT is $217.37M

What is the all-time high quarterly cash from financing for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high quarterly cash from financing is $217.37M

What is Cogent Biosciences, Inc. quarterly cash from financing year-on-year change?

Over the past year, COGT quarterly cash from financing has changed by +$216.74M (+34734.46%)

What is Cogent Biosciences, Inc. TTM cash from financing?

The current TTM cash from financing of COGT is $289.59M

What is the all-time high TTM cash from financing for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high TTM cash from financing is $377.15M

What is Cogent Biosciences, Inc. TTM cash from financing year-on-year change?

Over the past year, COGT TTM cash from financing has changed by +$75.17M (+35.05%)
On this page